Back

Pharmacometabolomics analysis of plasma and urine to identify clopidogrel exposure metabolic biomarkers

10 November 2019 (09:00 - 13:00)
Organised by:
Congress Presentation Part of: Poster Session Sunday Pharmacotherapy ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Muhamad Ali Sheikh Abdul Kader

Hospital Serdang, Serdang (Malaysia)

31 More presentations in this session

Presentation thumbnail
Evaluation of coronary endothelial dysfunction by positron emission tomography: does gender make a difference
Doctor A. Aljizeeri (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Fragmented QRS in prediction of ischemic heart disease diagnosed by stress cardiovascular magnetic resonance imaging
Doctor P. Yooprasert (Bangkok, TH)
Abstract
Presentation thumbnail
Identifying predictors for all-cause mortality at admission, 1 and 3 years after admission for acute decompensated heart failure amongst patients with atrial fibrillation.
Doctor H. Koh (Kuala Lumpur, MY)
Abstract Slides
Presentation thumbnail
Withdrawal of beta- blockers and ACE inhibitors after left ventricular systolic function recovery in patient with dilated cardiomyopathy randomized control trial
Doctor A. Bakhsh (Makkah, SA)
Abstract Slides
Presentation thumbnail
The differential impact of renal resistive index on future cardiovascular event in the hospitalised cardiovascular patients according to left ventricular ejection fraction: J-VAS study
Doctor P. Kotruchin (Khon Kaen, TH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session Sunday

The Event

Event poster

ESC Asia with APSC & AFC

10 November 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020
thumbnail
Congress Session
French symposium: future directions in the treatment of acute coronary syndromes
26 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources